acute ischemic stroke
Conditions
Interventions
Experimental group1.1:Danhong injection+Western standard treatment
Experimental group 1.2:Shenmai injection+Western standard treatment
Experimental group 1.3:Danhong injection+Shenmai injection+Western standa
Experimental group 2:Danhong injection+Shenmai injection+Western standa
control group 1:Western standard treatment
control group2:Western standard treatment
Sponsors
China Academy of Chinese Medicine Sciences, Guang'An Men Hospital
Eligibility
Sex/Gender
All
Age
35 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Symptoms and signs of clinically definite acute ischemic stroke.Qi deficiency and blood stasis syndrome of TCM; (2) Patients beyond thrombolysis treatment 3 & 6 hours time window with acute ischemic stroke; (3) Adults between 35-75 years old; (4) National institutes of health stroke scale (NIHSS) score>=7; (5) Modified Rankin score<=1 (The first acute ischemic stroke or recurrent stroke); (6) Signed written informed consent.
Exclusion criteria
Exclusion criteria: (1) The patient had received thrombolysis treatment; (2) Acute ischaemic stroke past 7days; (3) Aged 75 years; (4) NIHSS score220mmHg or Diastolic Blood Pressure >120mm Hg; (11) the patient should be excluded if their blood glucose is 20.0 mmol/L.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The onset 90th day mRS score = 2 points the proporty;Number of patients with Barthel Index score =75; | — |
Secondary
| Measure | Time frame |
|---|---|
| Change of TCM symdroms;Change of Brunnstrom scores;NIHSS score; | — |
Countries
China
Contacts
Public ContactHu Jingqing
Outcome results
None listed